Abbott India Share Price
26105.00+160.00 (+0.62%)
-19.86% past 1 Year
News
Abbott India sees Rs 25.70 crore NSE block trade for 9,136 shares
Equity
ABBOTINDIA
Abbott India to manage Awiqli distribution as Novo Nordisk’s longtime partner
Equity
ABBOTINDIA
Abbott India sees Rs 20.53 crores NSE block trade at steep price
Equity
ABBOTINDIA
Abbott India sees Rs 25.58 crores NSE block trade at steep share price
Equity
ABBOTINDIA
Block trade executed in ABBOTINDIA shares on NSE at steep price level
Equity
ABBOTINDIA
Abbott India informs about press release
Equity
ABBOTINDIA
Abbott India informs about notice of postal ballot
Equity
ABBOTINDIA
Abbott India reports Profit after tax of 394.93 Crores, in the March 2026 quarter
Equity
ABBOTINDIA
Abbott India Reports Strong Q4 EBITDA Growth to Rs 480 Crores, Margin Expands to 28.09%
Equity
ABBOTINDIA
Abbott India Q4FY25 Net Profit Rises 6.8% YoY to Rs 395 Crore, Revenue Up 6.3% to Rs 1700 Crore
Equity
ABBOTINDIA
Abbott India informs about change in management
Equity
ABBOTINDIA
JPMorgan Downgrades Abbott India to Neutral, Target Rs 27,500 on Growth Concerns.
Equity
ABBOTINDIA
Abbott India informs about certificate
Equity
ABBOTINDIA
Abbott India inches up on inking pact with Novo Nordisk India to launch Extensior
Equity
ABBOTINDIA
Abbott India inks pact with Novo Nordisk India to launch Extensior
Equity
ABBOTINDIA
Abbott India Partners with Novo Nordisk to Launch Extensior Semaglutide for Type 2 Diabetes in India.
Equity
ABBOTINDIA
Abbott India informs about press release
Equity
ABBOTINDIA
Abbott India - Quaterly Results
Equity
ABBOTINDIA
Abbott India reports Profit after tax of 375.96 Crores, in the December 2025 quarter
Equity
ABBOTINDIA
Abbott India Q3 FY26 EBITDA Rises 4.5% YoY to Rs 460 Crore with Stable 26.9% Margin.
Equity
ABBOTINDIA